Source: Annual Congress 2005 - Exercise in respiratory disease
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Donnelly, I. Carl, A. Smyth, M. Riley, D. P. Nicholls (Belfast, United Kingdom). Exercise limitation in systemic sclerosis. Eur Respir J 2005; 26: Suppl. 49, 754

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary involvement and exercise limitation in patients with systemic sclerosis Source: Eur Respir J 2004; 24: Suppl. 48, 53s Year: 2004 Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019 Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Exercise limitation in stable systemic sclerosis: insights from cardiopulmonary exercise test Source: International Congress 2019 – Exercise testing and respiratory muscles in various diseases Year: 2019 Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis Source: Eur Respir J 2016; 48: 1658-1667 Year: 2016 Unmasking hidden disease: exercise pulmonary haemodynamics in systemic sclerosis Source: Eur Respir J, 50 (1) 1700885; 10.1183/13993003.00885-2017 Year: 2017 Impaired exercise performance in systemic sclerosis. Clinical correlations Source: Annual Congress 2008 - Exercise: system responses Year: 2008 Exercise pulmonary hemodynamics in systemic sclerosis patients – Implications for outcome Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 To stress or not to stress? Exercise pulmonary haemodynamic testing in systemic sclerosis Source: Eur Respir J 2016; 48: 1549-1552 Year: 2016 Fluid challenge test and pulmonary haemodynamics in patients with systemic sclerosis Source: International Congress 2017 – PAH and CTEPH Year: 2017 The genetics of systemic sclerosis Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Lung function and pulmonary hypertension in systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary hypertension in systemic sclerosis: different phenotypes Source: Eur Respir Rev, 26 (145) 170056; 10.1183/16000617.0056-2017 Year: 2017 Screening for pulmonary arterial hypertension in systemic sclerosis Source: Eur Respir Rev 2009; 18: 162-169 Year: 2009 Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 The adoption of nintedanib in systemic sclerosis: the SENSCIS study Source: Breathe, 16 (2) 200005; 10.1183/20734735.0005-2020 Year: 2020 Clinical and laboratory features of systemic sclerosis with pulmonary involvement Source: Eur Respir J 2001; 18: Suppl. 33, 512s Year: 2001 Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus Source: Eur Respir Rev 2011; 20: 277-286 Year: 2011